Volume 58, Issue 10 pp. 2958-2978
Review

Cubosomes: The Next Generation of Smart Lipid Nanoparticles?

Dr. Hanna M. G. Barriga

Dr. Hanna M. G. Barriga

Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden

Search for more papers by this author
Dr. Margaret N. Holme

Dr. Margaret N. Holme

Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden

Search for more papers by this author
Prof. Molly M. Stevens

Corresponding Author

Prof. Molly M. Stevens

Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden

Departments of Materials and Bioengineering and Institute of Biomedical Engineering, Imperial College London, London, UK

Search for more papers by this author
First published: 21 June 2018
Citations: 388

Graphical Abstract

Cubosomes are nanoparticles with an internal periodic lipid membrane separated by two distinct water channels. The surface is stabilized by a polymer outer corona. Recent advances have enabled the rational design of cubosome systems. Key considerations are outlined for engineering cubosomes for tailor-made applications including delivery, biosensing, and medical applications.

Abstract

Cubosomes are highly stable nanoparticles formed from the lipid cubic phase and stabilized by a polymer based outer corona. Bicontinuous lipid cubic phases consist of a single lipid bilayer that forms a continuous periodic membrane lattice structure with pores formed by two interwoven water channels. Cubosome composition can be tuned to engineer pore sizes or include bioactive lipids, the polymer outer corona can be used for targeting and they are highly stable under physiological conditions. Compared to liposomes, the structure provides a significantly higher membrane surface area for loading of membrane proteins and small drug molecules. Owing to recent advances, they can be engineered in vitro in both bulk and nanoparticle formats with applications including drug delivery, membrane bioreactors, artificial cells, and biosensors. This review outlines recent advances in cubosome technology enabling their application and provides guidelines for the rational design of new systems for biomedical applications.

Conflict of interest

The authors declare no conflict of interest.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.